Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$25.26 - $29.6 $187,681 - $219,928
7,430 New
7,430 $207,000
Q4 2022

Jan 30, 2023

SELL
$41.75 - $54.5 $17,201 - $22,454
-412 Reduced 5.84%
6,643 $340,000
Q3 2022

Nov 03, 2022

SELL
$43.76 - $53.42 $47,304 - $57,747
-1,081 Reduced 13.29%
7,055 $309,000
Q1 2022

Apr 20, 2022

SELL
$45.75 - $56.69 $52,429 - $64,966
-1,146 Reduced 12.35%
8,136 $421,000
Q4 2021

Jan 12, 2022

SELL
$41.32 - $61.25 $18,759 - $27,807
-454 Reduced 4.66%
9,282 $548,000
Q3 2021

Oct 12, 2021

BUY
$39.25 - $50.42 $15,464 - $19,865
394 Added 4.22%
9,736 $419,000
Q2 2021

Jul 22, 2021

SELL
$35.91 - $40.68 $10,880 - $12,326
-303 Reduced 3.14%
9,342 $366,000
Q1 2021

Apr 14, 2021

BUY
$33.49 - $37.77 $26,557 - $29,951
793 Added 8.96%
9,645 $349,000
Q4 2020

Jan 15, 2021

BUY
$33.47 - $42.56 $39,728 - $50,518
1,187 Added 15.49%
8,852 $326,000
Q3 2020

Oct 21, 2020

SELL
$31.75 - $37.25 $24,511 - $28,757
-772 Reduced 9.15%
7,665 $281,000
Q2 2020

Jul 08, 2020

BUY
$30.12 - $36.54 $230,297 - $279,384
7,646 Added 966.62%
8,437 $276,000
Q2 2020

Jul 08, 2020

SELL
$30.12 - $36.54 $270,296 - $327,909
-8,974 Reduced 91.9%
791 $276,000
Q1 2020

Apr 13, 2020

BUY
$27.03 - $38.62 $52,600 - $75,154
1,946 Added 24.89%
9,765 $319,000
Q3 2019

Oct 16, 2019

SELL
$32.49 - $42.13 $4,418 - $5,729
-136 Reduced 1.71%
7,819 $281,000
Q2 2019

Jul 18, 2019

BUY
$36.98 - $41.52 $10,946 - $12,289
296 Added 3.86%
7,955 $345,000
Q1 2019

May 30, 2019

BUY
$37.5 - $41.2 $37,500 - $41,200
1,000 Added 15.02%
7,659 $325,000
Q4 2018

May 30, 2019

BUY
$38.47 - $43.86 $256,171 - $292,063
6,659 New
6,659 $291,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Private Capital Management LLC Portfolio

Follow Private Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Management LLC with notifications on news.